G&E Herbal Biotechnology Co., Ltd. was established in August 2002 and, in October of the same year, was approved by the Southern Taiwan Science Park under the Ministry of Science and Technology as a high‑tech enterprise to set up its manufacturing facility. Drug development is inherently cross‑disciplinary. Accordingly, G&E’s R&D team integrates expertise in biochemistry, physiology, molecular biology, pharmacology, horticulture, animal testing, and quality control analysis. The team is led by Dr. Kou‑Wha Kuo, who served 23 years in the Department of Biochemistry at Kaohsiung Medical University and brings more than 40 years of drug development experience. G&E focuses on transforming natural plants into Western‑medicine‑grade botanical drugs to address clinically challenging diseases, including cancers as well as hepatic, biliary, renal, and other disorders. The company’s current paid‑in capital is NT$589,996,000.
G&E’s Plant Bioactivity and Mechanism Research Center was approved by the National Science Council. With research professionals and equipment on par with leading academic institutions, the company is recognized as one of Taiwan’s few specialized botanical new drug development centers. Over the years, G&E has successfully completed multiple government‑funded projects and academia‑industry collaborations. Notably, its new drug SR‑T100 gel has been approved by the Ministry of Health and Welfare for human clinical trials, completed Phase III clinical trials, and received FDA approval for Phase II clinical trials in the United States for the treatment of actinic keratosis and condyloma acuminatum. The company is also advancing development of an injectable formulation for treating malignant ascites in terminal cancer patients.
G&E operates government‑certified facilities, including a botanical extraction plant, food supplement production lines, skincare product manufacturing, and a PIC/S GMP pharmaceutical plant. From contracted cultivation and quality analysis to mass production, all processes are managed in‑house, enabling the company to deliver natural botanical supplements, plant‑based functional cosmetics, pharmaceuticals, and clinical trial medications with consistent quality and reliability.
On March 21, 2011, G&E was approved for OTC listing (Stock Code 4911) by the Taipei Exchange. The company adheres to ethical management, does not engage in reinvestment or bank borrowing, and all land and facilities are self-owned.
In recent years, the company has actively implemented ESG, promoting corporate governance, social responsibility, and environmental protection, dedicated to:
With its botanical new drug technologies and complete production capabilities, G&E has become a key leader in Taiwan’s botanical new drug industry. The company will continue developing innovative drugs, building an international brand, and making its mark in the global biopharmaceutical market.
| Main Department | Business Scope |
| Audit Office |
•Evaluate internal controls to identify risks and recommend improvements. •Promote efficient management oversight that balances cost with operational effectiveness. •Develop and update audit procedures to ensure compliance and consistency. •Plan and execute annual audits, monitor irregularities, and drive corrective actions. •Conduct regular and ad hoc audits, issue reports, and verify remediation. •Lead self‑inspection programs to strengthen accountability across departments. •Supervise budgets and support senior management with governance and oversight tasks. |
| Executive Office |
•Formulate corporate strategies and support project research, planning, and implementation. •Set and track business objectives, ensuring alignment with operating goals. •Assist the CEO in handling key business matters. •Supervise operating procedures and manage contracts, title deeds, procurement, expenses, and compensation. •Review budgets and operating reports prepared by finance and accounting units. •Plan and promote project‑related initiatives to drive business growth. •Manage stock affairs and maintain strong relations with directors, supervisors, shareholders, and institutional investors. |
| R&D Department |
•Research, develop, and design new technologies and products, while providing industry insights. •Execute research projects to advance innovation and product development. •Manage technology transfer processes for new product commercialization. •Establish pilot and initial mass production conditions to ensure scalability. •Monitor laboratory quality and processes to maintain compliance and standards. |
| Quality Control Department |
•Improve production processes and yields, and oversee laboratory accreditation programs. •Manage quality objectives to ensure compliance and continuous improvement. •Control product identification, inspection, and measurement across all stages of production. •Oversee finished goods flow to safeguard efficiency and accuracy in distribution. |
| Manufacturing Department |
•Assess raw material requirements to ensure adequate supply for production needs. •Arrange and control production scheduling for efficiency and timely delivery. •Oversee warehouse management to safeguard inventory accuracy and flow. •Adjust and optimize mass production conditions to improve yields and scalability. •Manage production quality to meet standards and customer expectations. •Maintain occupational safety and environmental protection by enforcing compliance and preventive measures. |
| Marketing Department |
•Formulate product marketing strategies and develop markets. •Collect, organize, and analyze market and industry information to guide decision‑making and business planning. •Manage product sales and after‑sales service, ensuring customer satisfaction and performance targets. •Coordinate internal communication and build the company’s external image through branding and public relations. •Plan and execute marketing campaigns, PR initiatives, media strategies, and exhibitions, including negotiations with strategic partners. •Develop corporate materials and digital assets—draft publications, promotional content, press releases, and maintain the corporate website. •Plan and execute marketing projects, strengthen relationships in the medical field, and promote to corporate users, while conducting business forecasting, evaluation, and analysis to formulate business plans and achieve operating targets and sales performance. |
| Administration Department |
•Plan and oversee day‑to‑day company affairs to ensure smooth operations. •Manage HR and administrative functions, including recruitment, training, performance appraisal, promotion, compensation, and benefits. •Oversee raw materials and general procurement, ensuring cost efficiency, quality assurance, and reliable supply to support production and operations. •Manage company equipment and assets, oversee general administration, facilities maintenance, and occupational safety and health. •Promote projects and support training initiatives that strengthen business capabilities. •Plan and implement IT and digitalization projects, ensuring effective follow‑up and system integration. •Handle regulatory filings and public disclosures to maintain compliance with competent authorities. |
| Finance Department |
•Prepare the annual budget and perform variance analysis with control over actual results. •Manage cash handling, fund allocation, and treasury operations to ensure liquidity and financial stability. •Oversee accounting, bookkeeping, and cost accounting to maintain accurate records and support decision‑making. •File business tax returns and required reports regularly with the Park Administration. •Handle tax filings and annual returns, ensuring compliance with relevant regulations. •Coordinate accounting and audit matters related to subsidy programs for R&D projects. •Provide financial data and manage regulatory filings and disclosures required by competent authorities. |